SavedAdd your journal

Journals / Bayburt Üniversitesi Fen Bilimleri Dergisi / 2022 / Cilt: 5 - Sayı: 1

Clarification Of The Structure Of 1,4-Bis(2-Chloro-4-Nitrophenyl)Piperazine Molecule And Its Molecular Docking Analysis With DNA

1,4-Bis(2-Kloro-4-Nitrofenil)Piperazin Molekülünün Yapısının Aydınlatılması ve DNA ile Moleküler Kenetlenme Analizi

A. Demet DEMİRAG
Sefa ÇELİK
Berkant İLGİN
Ayşen ÖZEL
Sevim AKYÜZ
Pages
19–25
Publication Date
2022-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Depending on the molecular docking studies, the 1,4-Bis(2-chloro-4-nitrophenyl)piperazine was predicted to possess strong anti-tumor effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Piperazine-derived molecules have important anticancer activities.
📊
Key Findings & Data:In this study, conformational analysis was performed using the Spartan06 program to elucidate the structure of 1,4-Bis(2-chloro-4-nitrophenyl)piperazine (C16H14Cl2N4O4).
💡
Conclusion & Impact:Depending on the molecular docking studies, the 1,4-Bis(2-chloro-4-nitrophenyl)piperazine was predicted to possess strong anti-tumor effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Piperazin · Antikanser · DNA

Abstract

Piperazine-derived molecules have important anticancer activities. In this study, conformational analysis was performed using the Spartan06 program to elucidate the structure of 1,4-Bis(2-chloro-4-nitrophenyl)piperazine (C16H14Cl2N4O4). Among the conformations determined as a result of the conformation analysis, the molecular structure with the lowest energy was determined. DNA is an important target for anticancer molecules. For this reason, the interaction of 1,4-Bis(2-chloro-4-nitrophenyl)piperazine with DNA (PDB ID: 1BNA) was investigated through docking simulations. The obtained lowest energy conformer of the title molecule was taken as the starting geometry of the ligand for docking simulations with target DNA. As a result, the binding affinity and the binding mode of the title molecule with DNA were evaluated. 1,4-Bis(2-chloro-4-nitrophenyl)piperazine has -7.5 and -7.4 kcal/mol binding affinities to DNA, in two different sites. Depending on the molecular docking studies, the 1,4-Bis(2-chloro-4-nitrophenyl)piperazine was predicted to possess strong anti-tumor effects.

Özet

Piperazin türevi moleküller önemli antikanser aktivitelere sahiptir. Bu çalışmada 1,4-Bis(2-kloro-4-nitrofenil)piperazinin (C16H14Cl2N4O4) yapısını aydınlatmak için Spartan06 programı kullanılarak konformasyon analizi yapılmıştır. Konformasyon analizi sonucunda belirlenen konformasyonlar arasından en düşük enerjiye sahip moleküler yapı belirlenmiştir. DNA antikanser moleküller için önemli bir hedeftir. Bu nedenle 1,4-Bis(2-kloro-4-nitrofenil)piperazinin DNA (PDB ID: 1BNA) ile etkileşimi kenetlenme simülasyonları ile incelenmiştir. Molekülün elde edilen en düşük enerjili konformeri, hedef DNA ile kenetlenme simülasyonları için ligandın başlangıç geometrisi olarak alınmıştır. Sonuç olarak, DNA ile molekülün bağlanma afinitesi ve bağlanma modu değerlendirilmiştir. 1,4-Bis(2-kloro-4-nitrofenil)piperazin, DNA ile iki farklı bölgede -7.5 ve -7.4 kcal/mol bağlanma afinitelerine sahiptir. Moleküler kenetlenme çalışmalarına göre 1,4-Bis(2-kloro-4-nitrofenil)piperazinin güçlü anti-tümör etkilere sahip olduğu tahmin edilmektedir.

🔖

Cite This Article

DEMİRAG, A. D., ÇELİK, S., İLGİN, B., ÖZEL, A., AKYÜZ, S. (2022). Clarification Of The Structure Of 1,4-Bis(2-Chloro-4-Nitrophenyl)Piperazine Molecule And Its Molecular Docking Analysis With DNA. Bayburt Üniversitesi Fen Bilimleri Dergisi, Cilt: 5 - Sayı: 1, 19–25. https://ajindex.com/articles/741245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Potten, C. S., Owen, G., & Booth, D. (2002). Intestinal stem cells protect their genome by selective segregation of template DNA strands. Journal of cell science, 115(11), 2381-2388.
  2. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71(3), 209-249.
  3. El-Deeb, I. M., & Lee, S. H. (2010). Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. Bioorganic & medicinal chemistry, 18(11), 3961-3973.
  4. Vardanyan, R., & Hruby, V. (2016). Synthesis of best-seller drugs. Academic press. Kaushik, N. K., Kaushik, N., Attri, P., Kumar, N., Kim, C. H., Verma, A. K., & Choi, E. H. (2013). Biomedical importance of indoles. Molecules, 18(6), 6620-6662.
  5. Yarim, M., Koksal, M., Durmaz, I., & Atalay, R. (2012). Cancer cell cytotoxicities of 1-(4-substitutedbenzoyl)-4-(4-chlorobenzhydryl) piperazine derivatives. International journal of molecular sciences, 13(7), 8071-8085.
  6. Çalışkan, B., Yılmaz, A., Evren, İ., Menevşe, S., Uludag, O., & Banoglu, E. (2013). Synthesis and evaluation of analgesic, anti-inflammatory, and anticancer activities of new pyrazole-3 (5)-carboxylic acid derivatives. Medicinal Chemistry Research, 22(2), 782-793.
  7. Xia, Y., Dong, Z. W., Zhao, B. X., Ge, X., Meng, N., Shin, D. S., & Miao, J. Y. (2007). Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Bioorganic & medicinal chemistry, 15(22), 6893-6899.
  8. Xia, Y., Fan, C. D., Zhao, B. X., Zhao, J., Shin, D. S., & Miao, J. Y. (2008). Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. European journal of medicinal chemistry, 43(11), 2347-2353.
  9. Pirol, Ş. C. (2013). Diarilpirazol Türevi Bileşiklerin Sentezi Ve Antikanser Etkilerinin Araştırılması Üzerinde Çalışmalar. Gazi Üniversitesi (Doktora Tezi), 1-114.
  10. Li, X., Lu, X., Xing, M., Yang, X. H., Zhao, T. T., Gong, H. B., & Zhu, H. L. (2012). Synthesis, biological evaluation, and molecular docking studies of N, 1, 3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Bioorganic & medicinal chemistry letters, 22(11), 3589-3593.
  11. Lee, Y. B., Gong, Y. D., Kim, D. J